Quantcast
Skip to Main Content

News & Research

Donate Today!

All Researchers

   

Items 201 - 300 of 329  Previous1234Next
  • O'Dell, Laura, PhD
    The University of Texas at El Paso
    El Paso, Texas
    Diabetes Enhances Susceptibility to the Rewarding Effects of Nicotine
    01/01/13- 12/31/13
  • O'Dell, Laura, E PhD
    The University of Texas at El Paso
    El Paso, Texas
    Diabetes Enhances Susceptibility to the Rewarding Effects of Nicotine
    07/01/12- 06/30/15
  • O'Donnell, Michael, J. PhD
    University of Illinois at Chicago
    Chicago, Illinois
    13C NMR studies of lipoprotein metabolism in diabetes cardiomyopathy
    Type 2 diabetes
    01/01/12- 12/31/14
  • O'Donnell, Martha, Eaton PhD
    University of California, Davis
    Davis, California
    Role of blood-brain barrier Na transporters in diabetic ischemic stroke
    01/01/13- 12/31/15
  • Oberholzer, Jose, MD
    University of Illinois at Chicago
    Chicago, Illinois
    Generation of an unlimited source of insulin producing beta cells for transplant
    Type 1 diabetes
    01/01/13- 12/31/13
  • Oberholzer, Jose , MD
    University of Illinois at Chicago
    Chicago, Illinois
    Microfluidic-based strategies for hypoxia preconditioning of microencapsulated human islets for transplantation
    07/01/12- 06/30/15
  • OBrien, Sarah, H MD
    Research Institute at Nationwide Children's Hospital
    Columbus, Ohio
    Safety and effectiveness of hormonal contraception in women with diabetes
    01/01/13- 12/31/14
  • Odorico, Jon, S. MD
    University of Wisconsin System
    Madison, Wisconsin
    A tissue-specific niche to promote endocrine differentiation from human pluripotent stem cells
    01/01/13- 12/31/13
  • Osei, Kwame, MD, FACE, FACP
    Ohio State University Medical Center
    Columbus, Ohio
    Effects of diet--induced weight loss on HDL functionality in dysglycemic African Americans and Whites
    Type 2 diabetes
    01/01/11- 12/31/13
  • Ozcan, Umut, MD
    Children's Hospital Boston
    Boston, Massachusetts
    Role Of ER Stress and ATF4 In Development Of Leptin Resistance
    07/01/09- 06/30/14
  • Palaniappan, Latha, P MD
    Palo Alto Medical Foundation Research Institute
    Palo Alto, California
    Gestational diabetes in minority populations: predictors, problems and progression
    01/01/13- 12/31/13
  • Palaniappan, Latha, P. MD
    Palo Alto Medical Foundation
    Palo Alto, California
    Gestational diabetes in Asian Americans: predictors, problems and progression
    07/01/12- 06/30/15
  • Parikh, Samir, M MD
    Beth Israel Deaconess Medical Center
    Boston, Massachusetts
    Tie2 signaling impairment in diabetic nephropathy
    01/01/13- 12/31/15
  • Parks, Elizabeth, Jane PhD
    University of Texas Southwestern Medical Center at Dallas
    Dallas, Texas
    Insulin resistance in the control of intestinal lipid metabolism
    01/01/13- 12/31/15
  • Patti, Mary, Elizabeth MD
    Joslin Diabetes Center
    Boston, Massachusetts
    STARS and SRF: molecular mediators of diabetes risk and novel therapeutic targets
    07/01/12- 06/30/15
  • Patti, Mary, Elizabeth MD
    Joslin Diabetes Center
    Boston, Massachusetts
    Molecular Mechanisms of Diabetes Risk
    07/01/12- 06/30/16
  • Periasamy, Muthu,
    The Ohio State University
    Columbus, Ohio
    How do deficient insulin signaling pathways affect skeletal muscle growth, maintenance, and function in a rodent model of type 2 diabetes mellitus?
    07/01/11- 06/30/14
  • Perreault, Leigh, MD
    University of Colorado Health Science Center
    Aurora, Colorado
    Exploring defects in glucose production and sensing in people with impaired fasting glucose
    07/01/09- 06/30/14
  • Pessin, Jeffrey, E. PhD
    Albert Einstein College of Medicine
    Bronx, New York
    Insulin signaling and metabolic regulation
    07/01/09- 06/30/13
  • Pessin, Jeffrey, E PhD
    Albert Einstein College of Medicine
    Bronx, New York
    Molecular mechanisms regulating nuclear SREBP-1c stability and lipogenesis
    07/01/12- 06/30/15
  • Petersen, Kitt, Mia Falk MD
    Yale University School of Medicine
    New Haven, Connecticut
    Mechanism of insulin resistance in aging
    07/01/09- 06/30/13
  • Peterson, Erik, J. MD
    University of Minnesota
    Minneapolis, Minnesota
    The role of PTPn22, diabetes risk gene, in Type 1 interferon regulation
    01/01/12- 12/31/14
  • Peti-Peterdi, Janos, MD
    University of Southern California
    Los Angeles, California
    Role of the succinate receptor GPR91 in diabetic nephropathy
    01/01/11- 12/31/13
  • Pfeffer, Suzanne, R. PhD
    Stanford University
    Stanford, California
    Rab GTPase control of GLUT4 trafficking in adipocytes
    07/01/12- 06/30/16
  • Philipson, Louis, MD, PhD
    The University of Chicago
    Chicago, Illinois
    National center for monogenic diabetes
    01/01/11- 12/31/13
  • Piganelli, Jon., B. PhD
    University of Pittsburgh
    Pittsburgh, Pennsylvania
    Redox modulation of LAG-3 for inhibition of diabetogenic TH1 cell activation
    Type 1 diabetes
    01/01/12- 12/31/14
  • Privalsky, Martin, L. PhD
    The Regents of the University of California
    Davis, California
    Protection against glucose intolerance conferred by alternative corepressor splicing.
    07/01/12- 06/30/15
  • Puigserver, Pere, PhD
    Dana-Farber Cancer Institute
    Boston, Massachusetts
    Transcriptional control of hepatic glucose production trough acetylation of PGC-1ALPHA
    Type 1 diabetes
    01/11/05- 06/30/10
  • Puigserver, Pere, PhD
    Dana-Farber Cancer Institute
    Boston, Massachusetts
    New components of the insulin signaling pathway and metabolic action: implications for diabetes
    07/01/12- 06/30/16
  • Qi, Ling, PhD
    Cornell University
    Ithaca, New York
    Regulation of systemic insulin sensitivity by adipocyte XBP1s
    Type 2 diabetes
    01/01/12- 12/31/14
  • Quon, Michael, J. PhD
    University of Maryland Baltimore
    Baltimore, Maryland
    Phosphorylation of Ser24 in IRS-1 by IRAK-1 promotes insulin resistance in mice
    01/01/13- 12/31/15
  • Rader, Daniel, J. MD
    University of Pennsylvania
    Philadelphia, Pennsylvania
    The role of ARV1 in adipose biology, obesity, and type 2 diabetes
    01/01/13- 12/31/13
  • Radhakrishnan, Ishwar, PhD
    Northwestern University
    Evanston, Illinois
    Transcription Regulation of Gluconeogenic Genes by CREB/ATF and TORC Factors
    01/01/12- 12/31/14
  • Rahmouni, Kamal, Ph.D.
    University of Iowa
    Iowa City, Iowa
    Mechanisms Mediating the Metabolic Effects of Amylin Action in the Brain
    01/01/11- 12/31/13
  • Raimondi, Giorgio, PhD
    University of Pittsburgh
    Pittsburgh, Pennsylvania
    Modulation of T cell reactivity by inflammatory cytokines and promotion of pancreatic islets transplant tolerance
    01/01/10- 12/31/13
  • Rasgon, Natalie, L. MD, PhD
    Stanford University School of Medicine
    Stanford, California
    Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults with Prediabetes
    07/01/12- 06/30/15
  • Reaven, Gerald, M. MD
    Stanford University
    Stanford, California
    Role of insulin resistance and insulin secretion in states of abnormal carbohydrate metabolism in human disease
    07/01/12- 06/30/16
  • Reaven, Gerald, MD
    Stanford University
    Stanford, California
    Addition of the long-acting glucagon-like peptide-1, liraglutide, to a calorie-restricted diet augments weight loss, and decreases risk of type 2 diabetes and cardiovascular disease in older, overweight/obese, prediabetic individuals.
    09/01/09- 08/31/12
  • Regensteiner, Judith, G. PhD
    University of Colorado
    Denver, Colorado
    Role of vascular function: oxygen delivery vs. oxygen utilitization in the exercise impairment in type 2 diabetes
    01/01/12- 12/31/14
  • Reijonen, Helena, Kristiina PhD
    Benaroya Research Institute at Virginia Mason
    Seattle, Washington
    Characterization of autoreactive memory T cells in T1D
    07/01/09- 06/30/12
  • Ridgway, William, M.D.
    University of Cincinnati College of Medicine
    Cincinnati, Ohio
    Soluble CD137 in Type one diabetes
    Type 1 diabetes
    01/01/11- 12/31/13
  • Robertson, R., Paul MD
    Pacific Northwest Research Institute
    Seattle, Washington
    Training in islet gene regulation and pancreas/islet transplantation programs.
    07/01/10- 06/30/14
  • Rodeheffer, Matthew, S PhD
    Yale University School of Medicine
    New Haven, Connecticut
    Characterization of brown and beige adipogenesis in vivo
    07/01/12- 06/30/15
  • Ruderman, Neil, B.
    Boston Medical Center
    Boston, Massachusetts
    AMPK regulation and biological relevance
    07/01/11- 06/30/15
  • Russell, Steven, Jon PhD
    Massachusetts General Hospital
    Boston, Massachusetts
    Closed-loop, microdose glucagon administration for the automated prevention and treatment of hypoglycemia
    Type 1 diabetes
    07/01/12- 06/30/15
  • Rutter, Jared,
    University of Utah
    Salt Lake City, Utah
    The role of PAS Kinase in insulin-induced lipogenesis
    07/01/11- 06/30/15
  • Sabatini, David,
    Whitehead Institute for Biomedical Research
    Cambridge, Massachusetts
    mTOR signaling in the control of glucose homeostasis
    07/01/11- 06/30/15
  • Saghatelian, Alan, PhD
    Harvard University
    Cambridge, Massachusetts
    Proteolysis-resistant peptide hormone analogs as potential anti-diabetic therapeutics
    07/01/12- 06/30/14
  • Saghatelian, Alan, PhD
    Harvard University
    Cambridge, Massachusetts
    Proteolysis-resistant peptide hormone analogs as potential anti-diabetic therapeutics
    07/01/12- 06/30/14
  • Saltiel, Alan, R. PhD
    University of Michigan
    Ann Harbor, Michigan
    Cell biology of insulin action
    07/01/07- 06/30/15
  • Samson, Susan, M.D.
    Baylor College of Medicine
    Houston, Texas
    Role of Wnt signaling and TCF7L2 for beta cell function and regeneration in mouse models of diabetes
    01/01/11- 12/31/14
  • Sautin, Yuri, PhD
    University of Florida
    Gainesville, Florida
    Prodiabetic role of purine degradation via xanthine oxidoreductase
    Type 2 diabetes
    07/01/12- 06/30/15
  • Scalia, Rosario, MD
    Temple University School of Medicine
    Philadelphia, Pennsylvania
    Regulation of leukocyte trafficking in visceral fat depots: the role of adiponectin
    Type 2 diabetes
    01/01/12- 12/31/14
  • Schauer, Irene, Elizabeth
    University of Colorado Denver
    Denver, Colorado
    The role of lipotoxicity in insulin resistance and cardiovascular and mitochondrial dysfunction in type 1 diabetes
    07/01/11- 06/30/14
  • Scherer, Philipp, E.
    UT Southwestern Medical Center at Dallas
    Dallas, Texas
    Adipocyte birth, death and recruitment during chronic excess caloric intake
    07/01/11- 06/30/15
  • Schrage, William, Greg PhD
    The Board of Regents of the University of Wisconsin System
    Madison, Wisconsin
    In vivo imaging of cerebrovascular structure and function in metabolic syndrome
    01/01/12- 12/31/13
  • Schur, Ellen, A MD
    University of Washington
    Seattle, Washington
    Is hypothalamic damage present in obese humans with type 2 diabetes?
    01/01/13- 12/31/14
  • Scott, Donald, K.
    University of Pittsburgh
    Pittsburgh, Pennsylvania
    ChREBP and glucose-stimulated beta cell proliferation
    07/01/11- 06/30/14
  • Seal, Rebecca, P. PhD
    University of Pittsburgh
    Pittsburgh, Pennsylvania
    The role of vglut3 in diabetic neuropathic pain
    07/01/12- 06/30/14
  • Serreze, David, V.
    The Jackson Laboratory
    Bar Harbour, Maine
    Dendritic cell therapies for autoimmune diabetes
    07/01/11- 06/30/14
  • Shalev, Anath, MD
    University of Alabama at Birmingham
    Birmingham, Alabama
    Identification of a TXNIP-regulated microRNA involved in insulin production
    07/01/12- 06/30/15
  • Sharma, Arun, J. PhD
    Joslin Diabetes Center
    Boston, Massachusetts
    Determine if enhancing MafA is sufficient to ameliorate beta cell dysfunction
    01/01/12- 12/31/14
  • Sherry, A., Dean PhD
    University of Texas Southwestern Medical Center at Dallas
    Dallas, Texas
    In vivo imaging of beta cell function with a zinc responsive contrast agent
    07/01/12- 06/30/16
  • Sherry, A., Dean PhD
    University of Texas Southwestern Medical Center at Dallas
    Dallas, Texas
    In vivo quantification of beta cell function with MRI using a zinc responsive contrast agent
    07/01/12- 06/30/14
  • Shirwan, Haval, PhD
    University of Louisville
    Louisville, Kentucky
    Immunomodulation with SA-FasL-engineered pancreatic islets for the treatment of type 1 diabetes
    01/01/12- 12/31/14
  • Shoelson, Steven, E. MD, PhD
    Joslin Diabetes Center
    Boston, Massachusetts
    Obesity-Induced Inflammation in Insulin Resistance, Type 2 Diabetes and Cardiovascular Disease
    07/01/08- 06/30/12
  • Shoelson, Steven, E. PhD
    Joslin Diabetes Center
    Boston, Massachusetts
    Interactions Between Metabolism, the Immune System, and the Microbiota in Type 2 Diabetes
    07/01/12- 06/30/16
  • Shoelson, Steven, MD, PhD
    Joslin Diabetes Center
    Boston, Massachusetts
    Circulating monocytes as targets of salicylate: biomarkers for response and potential mediators of pathogenesis
    01/01/12- 12/31/14
  • Shuldiner, Alan, R. MD
    University of Maryland School of Medicine
    Baltimore, Maryland
    Genomics of Type 2 Diabetes: Moving beyond GWAS to Mechanisms and Genome-informed Personalized Medicine
    07/01/12- 06/30/16
  • Siegelman, Mark, H. MD, PhD
    University of Texas Southwestern Medical Center at Dallas
    Dallas, Texas
    Increasing potent and specific autoreactive Treg in human T1D using a novel T cell adhesion biomarker CD44act
    01/01/12- 12/31/14
  • Simmons, Rebecca, Anne MD
    University of Pennsylvania School of Medicine
    Philadelphia, Pennsylvania
    Epigenetic regulation of ß-cell dysfunction
    Type 2 diabetes
    01/01/11- 12/31/13
  • Simpson, Ian, PhD
    Penn State College of Medicine
    Hershey, Pennsylvania
    Diabetes, stroke and the blood-brain barrier
    Type 2 diabetes
    01/01/11- 12/31/13
  • Skowyra, Dorota,
    Saint Louis University
    Saint Louis, Missouri
    Immunoproteasome in pancreatic beta cells
    07/01/11- 06/30/14
  • Smith, A. , Gordon
    Salt Lake City, Utah
    The effect of bariatric surgery on peripheral nerve and axonal regeneration
    Type 2 diabetes
    07/01/11- 06/30/14
  • Snell-Bergeon, Janet, K. PhD
    University of Colorado, Denver
    Aurora, Colorado
    Vascular disease, inflammation and hormones in women with type 1 diabetes
    01/01/10- 12/31/13
  • Sobrin, Lucia, M.D.
    Massachusetts Eye and Ear Infirmary
    Boston, Massachusetts
    Admixture mapping to discover diabetic retinopathy genes in African Americans
    Type 2 diabetes
    01/01/11- 12/31/13
  • Sprague, Randy, MD
    Saint Louis University
    St. Louis, Missouri
    Effect of type 2 diabetes on the erythrocyte and vascular control
    Type 2 diabetes
    01/01/11- 12/31/13
  • Staruschenko, Alexander, Ph.D.
    Medical College of Wisconsin
    Milwaukee, Wisconsin
    Mechanisms of ENaC regulation by insulin and PPARgamma
    Type 2 diabetes
    01/01/11- 12/31/13
  • Sussel, Lori,
    Columbia University
    New York, New York
    Regulation of adult beta cell function
    07/01/11- 06/30/15
  • Sweet, Ian, PhD
    University of Washington
    Seattle, Washington
    Role of cytochrome c translocation in insulin release
    Type 2 diabetes
    01/01/13- 12/31/14
  • Sykes, Megan,
    Columbia University
    New York, New York
    Cell-intrinsic immunopathology of type 1 diabetes in a humanized mouse model
    07/01/11- 06/30/15
  • Symons, John, David PhD
    University of Utah
    Salt Lake City, Utah
    Protein phosphatase 2A activation is required for lipid-induced, ceramide-mediated arterial dysfunction
    01/01/13- 12/31/13
  • Symons, John, David PhD
    University of Utah
    Salt Lake City, Utah
    Mechanisms whereby endogenous ceramide impairs eNOS signaling and arterial function
    01/01/12- 12/31/14
  • Szabo, Csaba, PhD
    The University of Texas Medical Branch
    Galveston, Texas
    Role of hydrogen sulfide in diabetic vascular complications
    07/01/12- 06/30/15
  • Tan, Yi, PhD
    University of Louisville
    Louisville, Kentucky
    Promotion of diabetic ischemic angiogenesis by SDF-1betaP2G mobilizing and SDF-1beta recruiting endothelial progenitor cells
    Type 2 diabetes
    01/01/13- 12/31/15
  • Tao, Ya-Xiong, PhD
    Auburn University
    Auburn, Alabama
    Rescue of intracellularly retained human melanocortin-4 receptor mutants
    Type 2 diabetes
    01/01/12- 12/31/14
  • Thamer, Mae, Ph.D.
    Medical Technology and Practice Patterns Institute
    Bethesda, Maryland
    Safe use of erythropoiesis-stimulating agents (ESAs) among diabetic patients undergoing dialysis
    01/01/11- 12/31/13
  • Tobacman, Joanne, Kramer MD
    University of Illinois at Chicago
    Chicago, Illinois
    Role of common food additive carrageenan in etiology of Type 2 diabetes
    Type 2 diabetes
    01/01/12- 12/31/14
  • Tong, Lu, MD, PhD
    Mayo Clinic Rochester
    Rochester, Minnesota
    Role of Ubiquitin-Proteasome System in the Regulation of Vascular BK Channel Beta1 Subunit Expression in Type 2 Diabetes
    01/01/12- 12/31/14
  • Tse, Hubert, Ming PhD
    University of Alabama at Birmingham
    Birmingham, Alabama
    Synergism of innate immune-derived reactive oxygen species and T cell effector responses in Type 1 diabetes
    07/01/12- 06/30/17
  • Tseng, Yu-Hua , PhD
    Joslin Diabetes Center
    Boston, Massachusetts
    Role of microRNA-455 in Brown Adipogenesis
    07/01/12- 06/30/15
  • Umetani, Michihisa,
    University of Texas Southwestern Medical Center
    Dallas, Texas
    Modulation of adiposity by 27-hydroxycholesterol, the first identified endogenous SERM
    07/01/11- 06/30/14
  • Umpierrez, Guillermo, MD
    Emory University School of Medicine
    Atlanta, Georgia
    Intensive insulin therapy in hyperglycemic patients undergoing coronary artery bypass surgery
    Type 2 diabetes
    01/01/11- 12/31/13
  • Vaisse, Christian, MD, PhD
    University of California, San Francisco
    San Francisco, California
    Molecular Genetics of Human Obesity
    07/01/08- 06/30/12
  • Vaisse, Christian, MD, PhD
    The Regents of the University of California
    San Francisco, California
    Molecular genetics of human obesity
    07/01/12- 06/30/16
  • Vaisse, Christian, MD, PhD
    University of Southern California, San Francisco
    San Francisco, California
    Melanocortin-specific micro RNAs: identification, function and role in human obesity
    07/01/12- 06/30/15
  • Von Herrath, Matthias, G. MD
    La Jolla Institute for Allergy and Immunology
    La Jolla, California
    Il-21 is a key regulator of nod t1d development
    07/01/09- 06/30/13
  • Wallet, Shannon, Margaret
    University of Florida
    Gainesville, Florida
    Osteoclast function in diabetes
    Type 1 diabetes
    07/01/11- 06/30/16
  • Wallia, Amisha, MD
    Northwestern University
    Chicago, Illinois
    A Study to Evaluate Glycemic Control on Outcomes Following Liver Transplantation
    01/01/13- 12/31/15
  • Wang, Yajing, M.D., Ph.D.
    Thomas Jefferson University
    Philadelphia, Pennsylvania
    Caveolin-3 as a novel therapeutic target in diabetic cardiomyocyte injury
    Type 2 diabetes
    01/01/11- 12/31/13
Items 201 - 300 of 329  Previous1234Next

 

Treatment With a Twist

New medications called SGLT-2 inhibitors target the kidneys.

Wondering if You’re at Risk?

MHA 72x72

My Health Advisor can calculate your risk and develop a health plan!

stepout-june2013_250x250

Tour de Cure

Tour de cure 72x72

Join more than 60,000 others riding to Stop Diabetes®.

Powered by Convio
nonprofit software